Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth ... ( CARLSBAD Calif. Aug. 4 /-...)

Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth Conference

Date:8/4/2009

CARLSBAD, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 29th Annual Canaccord Adams Global Growth Conference on Tuesday, August 11, 2009, at 1:00 p.m. ET at the Boston InterContinental Hotel.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com.

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:11/30/2009)...NASDAQ OMX Copenhagen: “EXQ”) announce...ood Screening Facility (ICCB-L) has been recognize...CCB-L supports investigators at Harvard Medical Sc...or high-throughput screening of small molecule and..., MA and Copenhagen, Denmark (PRWEB) November 30, ...

(Date:11/30/2009)...ember 30 Simbionix USA Corporation...ion systems, in collaboration,with GORE Medical Pr...io(TM),workshop for the first time at the upcoming...e Simbionix PROcedure Rehearsal Studio(TM) is the ...ns to create practice scenarios based on their,pat...

(Date:11/30/2009)...revealed that beverage can pull-tabs were being sw...nufacturers to stay-tabs. But a study presented to...ety of North America (RSNA) found that the new tab...iving factors leading the change in beverage can c...nt swallowing of the pull-tab and potential relate...

(Date:11/30/2009)...tern Medical Center researchers have found that in...tions associated with asthma. The findings, availa...s, suggest that interventions by parent mentors ... specialized topical training can effectively red...s and missed adult workdays. , "Childhood asthma...

(Date:11/29/2009)...ire/ -- The following is an investment opinion rel...c. ,, Intellivest Securities Research, Inc., ("... published a Report on BioClinica, Inc. ( BIOC) wh...hnology and medical device industries. A primary ...nd submit medical imaging portions of their submis...

Breaking Medicine News(10 mins):Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2 Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3 Health News:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 4 Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 2 Health News:Simbionix First Procedure Rehearsal Studio(TM) Training Workshop 3 Health News:Beverage can stay-tabs pose swallowing risk 2 Health News:Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find 2 Health News:Research Report on BioClinica, Inc. as Speculative Buy 2

[0] Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence [0] Simbionix First Procedure Rehearsal Studio(TM) Training Workshop [0] Beverage can stay-tabs pose swallowing risk [0] Parent mentors can improve the asthmatic care of minority children, UT Southwestern researchers find [0] Research Report on BioClinica, Inc. as Speculative Buy

...g,Inc. (NYSE: SRZ ) today reported financial resu...rise will host a conference call and webcast Frida...r was very difficult as we incurred a significant ...slashing development-related spending and selling ...

.... That,s what,Philadelphia Eagles placekicker Davi.... But here,s the kicker: Akers needs to boot a 64-...that,s stood for the past 38,years., Akers, a 10-... P90X. Akers turned to P90X to help regain his,str...

...rty, a Family Nurse Practitioner and herbalist ann...herbal first aid spray. This revolutionary, intern... tested on over 2,000 patients and has been clinic... (PRWEB) November 7, 2008 -- Noreen Mulvanerty, a ...

...evention, detection and treatment offer encouragem...urvivors by celebrating Cancer Awareness Month in ...l. (PRWEB) November 7, 2008 -- Advances in treatme...ty Disability Insurance representation company, th...

...y enjoy inflicting pain on others, research using ... Scans of the aggressive youth,s brains showed tha...lighted when the youth watched a video clip of som... first time that fMRI scans have been used to stud...

...enters are,proud to announce the addition of "Erin...ction., While searching for frames for her then 2... both an optician and a mother to a child with Dow...her special needs. Dellapina states her mission is...

Sunrise Reports Financial Results for Third Quarter 2008 KICKING FOR A CAUSE: Beachbody Pledges $1 million if Akers Breaks NFL Longest Field Goal Nurse Practitioner Creates Healing Herbal First-aid Spray More People Living Longer After Cancer Diagnosis Bullies may enjoy seeing others in pain Shopko Announces Erin's World Eyewear

(Date:11/29/2009)...wswire/ -- At the 95th Scientific Assembly an...rth America (RSNA) from November 29 to December 3 ...e will introduce its comprehensive portfolio for i... East Building/Lakeside Center, Hall D . Using ... therapy, the interventional radiologist navigat...

(Date:11/29/2009)...wswire/ -- FUJIFILM Medical Systems USA, Inc., the...FDM) with over 7,000 installations, is pleased to ...e in the US. The Aspire HD combines the use of ad...eneration detector technology and the smallest pix...resolution at a reduced dose for the patient. The...

(Date:11/27/2009)...revent illnesses caused by subtypes A and B influe...ewswire-USNewswire/ -- The U.S. Food and Drug Admi...18 years and older to prevent disease caused by in...tp://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO...s and Diagnostics in Siena, Italy, was approved us...

Breaking Medicine Technology:Minimally Invasive Procedure for Oncology 2 Minimally Invasive Procedure for Oncology 3 Minimally Invasive Procedure for Oncology 4 Minimally Invasive Procedure for Oncology 5 FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2 FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3 FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4 FDA Approves Agriflu Seasonal Influenza Vaccine 2 Cogdell Spencer Inc Declares Quarterly Dividend 48744 1 Cogdell Spencer Inc Declares Quarterly Dividend 48744 2 With 15 Million Kids Expected to Go Hungry This Summer Boys 26 Girls Clubs of America Partners With Morgan Stanley to Launch Million Meal Summer Pro 48742 1 With 15 Million Kids Expected to Go Hungry This Summer Boys 26 Girls Clubs of America Partners With Morgan Stanley to Launch Million Meal Summer Pro 48742 2 With 15 Million Kids Expected to Go Hungry This Summer Boys 26 Girls Clubs of America Partners With Morgan Stanley to Launch Million Meal Summer Pro 48742 3 With 15 Million Kids Expected to Go Hungry This Summer Boys 26 Girls Clubs of America Partners With Morgan Stanley to Launch Million Meal Summer Pro 48742 4 New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 1 New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 2 New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 3 New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 4 New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 5

[0] Minimally Invasive Procedure for Oncology [0] FUJIFILM's DR-based FFDM System Makes US Debut at RSNA [0] FDA Approves Agriflu Seasonal Influenza Vaccine

...sults Show Superior Decrease in Pain Scores Compar...ng Pharmaceuticals recently presented the results ...ting that EUFLEXXA(R) (1% sodium hyaluronate) was ...ritis (OA) at 26 weeks. The study showed that EUF... at 26 weeks in patients with OA of the knee.(1) ...

... OXFORD, England, May 13 Circassia Ltd, a specia...today announced that it has,initiated a phase II c...rgy,therapy. The treatment for allergic rhino-conj...rcassia,s ToleroMune(R) technology, which has prev...ients with cat allergies. Ragweed,is one of the le...

Other Medicine Technology:Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 2 Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain 3 Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy 2

Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy

...e laboratory and a worldwide leader in innovative ...n extensive test menu of highly complex and unique... Owned by the University of Utah, ARUP Laboratorie...university teaching hospitals and children's hospi...

Medicine Products:

Maternal Serum Screen, Alpha Fetoprotein, hCG, & Estriol Martin-Bell Syndrome Maprotiline Quantitation Manganese, Serum

Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth ...( CARLSBAD Calif. Aug. 4 /-...),Health